DETECHIP®: A Sensor for Drugs of Abuse *

Abstract:  The design and preliminary characterization of a novel sensor for drugs of abuse, DETECHIP®, is described in this proof‐of‐concept note. Combining both colorimetric and fluorimetric assays, DETECHIP® is suitable for lab and field use. More than a conventional spot test which provides a single “yes or no” answer, DETECHIP® provides twenty responses for a more complete characterization of suspect material. This is accomplished by visually noting colorimetric and fluorescent changes of carefully selected dyes upon the addition of test analytes, including drugs of abuse, with respect to controls. Color and fluorescence changes are recorded numerically so that a 20 digit identification code can be constructed for comparison of test analytes and known compounds. DETECHIP® is applicable to a variety of drugs, both plant‐derived and synthetic, addressing the need to use several different spot tests simultaneously for a single sample.

[1]  Fritz Feigl,et al.  Spot tests in organic analysis , 1956 .

[2]  G. H. Schenk,et al.  Fluorescence of acetylsalicylic acid in solution and its measurement in presence of salicylic acid. , 1970, Analytical chemistry.

[3]  S. Mulé,et al.  Evaluation of immunoassay methods for detection, in urine, of drugs subject to abuse. , 1974, Clinical chemistry.

[4]  M. Nielsen,et al.  The use of in vivo antisense oligonucleotide technology for the investigation of brain GABAA receptors , 1997, Neurochemistry International.

[5]  S J Salamone,et al.  Prevalence of drugs used in cases of alleged sexual assault. , 1999, Journal of analytical toxicology.

[6]  A. Negrusz,et al.  Highly sensitive micro-plate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair. , 1999, Journal of analytical toxicology.

[7]  Xiaohui He,et al.  Pharmacophore/Receptor Models for GABAA/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach , 2000 .

[8]  D J Crouch,et al.  Validation of twelve chemical spot tests for the detection of drugs of abuse. , 2000, Forensic science international.

[9]  P. Lillsunde,et al.  A comparison between on-site immunoassay drug-testing devices and laboratory results. , 2001, Forensic science international.

[10]  P. Janicak,et al.  Deposition of 7-aminoflunitrazepam and flunitrazepam in hair after a single dose of Rohypnol. , 2001, Journal of forensic sciences.

[11]  W. Lambert,et al.  Simultaneous determination of in total 17 opium alkaloids and opioids in blood and urine by fast liquid chromatography-diode-array detection-fluorescence detection, after solid-phase extraction. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Manfred Kollroser,et al.  Simultaneous analysis of flunitrazepam and its major metabolites in human plasma by high performance liquid chromatography tandem mass spectrometry. , 2002, Journal of pharmaceutical and biomedical analysis.

[13]  A. I. Golovko,et al.  The Influence of Ethanol on the Functional Status of GABAA Receptors , 2002, Biochemistry (Moscow).

[14]  S. Johansen,et al.  Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  Hanna Gm.  NMR regulatory analysis: enantiomeric purity determination for (R)-(-)-desoxyephedrine and antipode methamphetamine. , 2006 .

[16]  Jeremiah A Morris,et al.  Modified Cobalt Thiocyanate Presumptive Color Test for Ketamine Hydrochloride , 2007, Journal of forensic sciences.